Related Experiment Video
Updated: Sep 30, 2025

06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
551
Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary
Ritabrata Dutta1, Karim Zouaoui Boudjeltia2, Christos Kotsalos3
1University of Warwick, United Kingdom.
Plos Computational Biology
|March 10, 2022
Summary
This study introduces a new model for cardio/cerebrovascular diseases (CVD) detection, improving accuracy by analyzing platelet behavior. This personalized approach offers better diagnostics and treatment strategies for patients.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Cardiovascular Research
Background:
- Cardio/cerebrovascular diseases (CVD) pose significant health challenges.
- Current pathology tests for CVD are limited, failing to account for platelet activation dynamics and inter-individual variability.
Purpose of the Study:
- To develop a novel stochastic platelet deposition model for enhanced CVD detection.
- To create an inferential scheme for estimating biologically meaningful model parameters.
- To enable personalized pathology testing and treatment for CVD.
Main Methods:
- Developed a stochastic platelet deposition model.
- Employed approximate Bayesian computation with a discriminating summary statistic for parameter inference.
- Collected and analyzed data from healthy volunteers and diverse patient groups.
Main Results:
- Successfully inferred specific biological parameters differentiating patient types.
- Identified biological reasoning behind dysfunction in various patient cohorts.
- Demonstrated the model's capability to capture inter-individual variability in platelet dynamics.
Conclusions:
- The proposed model and inferential scheme offer a pathway to personalized CVD pathology tests.
- This approach allows for a deeper understanding of the biological basis of CVD in individual patients.
- Opens new avenues for targeted medical treatments for cardio/cerebrovascular diseases.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
382
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
382
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
143
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
143
Kaplan-Meier Approach
290
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
290

